Ginseng total saponin improves podocyte hyperpermeability induced by high glucose and advanced glycosylation endproducts

Journal of Korean Medical Science

Volumn 26, Issue 10, 2011, Pages 1316-1321

  Ha, Tae Sun ^a   Choi, Ji Young ^a   Park, Hye Young ^a   Lee, Jin Seok ^a  

^a Chungbuk National University College of Medicine   (South Korea)

Author keywords

Advanced glycosylation endproducts; Diabetic nephropathies; Ginseng total saponin; Podocytes; ZO 1

Indexed keywords

ADVANCED GLYCATION END PRODUCT; BETA CATENIN; GLUCOSE; MEMBRANE PROTEIN; PHOSPHOPROTEIN; PLANT MEDICINAL PRODUCT; PROTEIN ZO1; SAPONIN; ZONULA OCCLUDENS-1 PROTEIN;

ACTIN FILAMENT; ANIMAL; ARTICLE; CELL LINE; DIABETIC NEPHROPATHY; DRUG EFFECT; GLOMERULUS FILTRATION RATE; HYPERGLYCEMIA; METABOLISM; MOUSE; PANAX; PATHOLOGY; PATHOPHYSIOLOGY; PERMEABILITY; PHYSIOLOGY; PODOCYTE;

ACTIN CYTOSKELETON; ANIMALS; BETA CATENIN; CELL LINE; DIABETIC NEPHROPATHIES; GLOMERULAR FILTRATION RATE; GLUCOSE; GLYCOSYLATION END PRODUCTS, ADVANCED; HYPERGLYCEMIA; MEMBRANE PROTEINS; MICE; PANAX; PERMEABILITY; PHOSPHOPROTEINS; PLANT PREPARATIONS; PODOCYTES; SAPONINS;

EID: 84863053576     PISSN: 10118934     EISSN: 15986357     Source Type: Journal    
DOI: 10.3346/jkms.2011.26.10.1316     Document Type: Article

References (30)

1. Parving HH, Mauer M, Ritz E. Diabetic nephropathy. In: Brenner BM, editor. The kidney. Philadelphia, PA: WB Saunders, 2008, p 1265-98.
2. Kanwar YS, Wada J, Sun L, Xie P, Wallner EI, Chen S, Chugh S, Danesh FR. Diabetic nephropathy: mechanisms of renal disease progression. Exp Biol Med (Maywood) 2008; 233: 4-11.
3. Sharma K, Ziyadeh FN. Biochemical events and cytokine interactions linking glucose metabolism to the development of diabetic nephropathy. Semin Nephrol 1997; 17: 80-92.
4. Vlassara H. Protein glycation in the kidney: role in diabetes and aging. Kidney Int 1996; 49: 1795-804.
5. Mundel P, Kriz W. Structure and function of podocytes: an update. Anat Embryol (Berl) 1995; 192: 385-97.
6. Reiser J, Kriz W, Kretzler M, Mundel P. The glomerular slit diaphragm is a modified adherens junction. J Am Soc Nephrol 2000; 11: 1-8.
7. Mundel P, Shankland SJ. Podocyte biology and response to injury. J Am Soc Nephrol 2002; 13: 3005-15.
8. Stevenson BR, Siliciano JD, Mooseker MS, Goodenough DA. Identification of ZO-1: a high molecular weight polypeptide associated with the tight junction (zonula occludens) in a variety of epithelia. J Cell Biol 1986; 103: 755-66.
9. Chang YS, Seo EK, Gyllenhaal C, Block KI. Panax ginseng: a role in cancer therapy? Integr Cancer Ther 2003; 2: 13-33.
10. Attele AS, Zhou YP, Xie JT, Wu JA, Zhang L, Dey L, Pugh W, Rue PA, Polonsky KS, Yuan CS. Antidiabetic effects of Panax ginseng berry extract and the identification of an effective component. Diabetes 2002; 51: 1851-8.
11. Chung SH, Choi CG, Park SH. Comparisons between white ginseng radix and rootlet for antidiabetic activity and mechanism in KKAy mice. Arch Pharm Res 2001; 24: 214-8.
12. Banz WJ, Iqbal MJ, Bollaert M, Chickris N, James B, Higginbotham DA, Peterson R, Murphy L. Ginseng modifies the diabetic phenotype and genes associated with diabetes in the male ZDF rat. Phytomedicine 2007; 14:681-9.
13. Yuan HD, Shin EJ, Chung SH. Anti-diabetic effect and mechanism of Korean red ginseng in C57BL/KsJ db/db mice. J Ginseng Res 2008; 32: 187-93.
14. Sotaniemi EA, Haapakoshi E, Rautio A. Ginseng therapy in non-insulindependent diabetic patients. Diabetes Care 1995; 18: 1373-5.
15. Vogler BK, Pittler MH, Ernst E. The efficacy of ginseng. A systematic review of randomised clinical trials. Eur J Clin Pharmacol 1999; 55: 567-75.
16. Vuksan V, Sievenpiper JL, Wong J, Xu Z, Beljan-Zdravkovic U, Arnason JT, Assinewe V, Stavro MP, Jenkins AL, Leiter LA, Francis T. American ginseng (Panax quinquefolius L) attenuates postprandial glycemia in a time-dependent but not dose-dependent manner in healthy individuals. Am J Clin Nutr 2001; 73: 753-8.
17. Liu TP, Liu IM, Cheng JT. Improvement of insulin resistance by panax ginseng in fructose-rich chow-fed rats. Horm Metab Res 2005; 37: 146-51.
18. Luo JZ, Luo L. Ginseng on hyperglycemia: effects and mechanisms. Evid Based Complement Alternat Med 2009; 6: 423-7.
19. Kang KS, Kim HY, Yamabe N, Nagai R, Yokozawa T. Protective effect of sun ginseng against diabetic renal damage. Biol Pharm Bull 2006; 29:1678-84.
20. Kim HY, Kang KS, Yamabe N, Nagai R, Yokozawa T. Protective effect of heat-processed American ginseng against diabetic renal damage in rats. J Agric Food Chem 2007; 55: 8491-7.
21. Kang KS, Yamabe N, Kim HY, Park JH, Yokozawa T. Therapeutic potential of 20(S)-ginsenoside Rg(3) against streptozotocin-induced diabetic renal damage in rats. Eur J Pharmacol 2008; 591: 266-72.
22. Kang KS, Yamabe N, Kim HY, Park JH, Yokozawa T. Effects of heat-processed ginseng and its active component ginsenoside 20(S)-Rg3 on the progression of renal damage and dysfunction in type 2 diabetic Otsuka Long-Evans Tokushima Fatty rats. Biol Pharm Bull 2010; 33: 1077-81.
23. Mundel P, Reiser J, Zúñiga Mejía Borja A, Pavenstädt H, Davidson GR, Kriz W, Zeller R. Rearrangements of the cytoskeleton and cell contacts induce process formation during differentiation of conditionally immortalized mouse podocyte cell lines. Exp Cell Res 1997; 236: 248-58.
24. Ha TS, Song CJ, Lee JH. Effects of advanced glycosylation endproducts on perlecan core protein of glomerular epithelium. Pediatr Nephrol 2004; 19: 1219-24.
25. Kim YL, Chung SH. Renoprotective effects of Korean red ginseng. J Ginseng Res 2004; 28: 111-9.
26. Yokozawa T, Iwano M, Dohi K, Hattori M, Oura H. Inhibitory effects of ginseng on proliferation of cultured mouse mesangial cells. Nihon Jinzo Gakkai Shi 1994; 36: 13-8.
27. Park MJ, Bae CS, Lim SK, Kim DI, Lim JC, Kim JC, Han HJ, Moon JH, Kim KY, Yoon KC, Park SH. Effect of protopanaxadiol derivatives in high glucose-induced fibronectin expression in primary cultured rat mesangial cells: role of mitogen-activated protein kinases and Akt. Arch Pharm Res 2010; 33: 151-7.
28. Zhang LN, Xie XS, Zuo C, Fan JM. Effect of ginsenoside Rgl on the expression of TNF-alpha and MCP-1 in rats with diabetic nephropathy. Sichuan Da Xue Xue Bao Yi Xue Ban 2009; 40: 466-71.
29. Ha TS. High glucose and advanced glycosylation end products increased podocyte permeability via PI3K/Akt signaling. J Mol Med (Berl) 2010; 88: 391-400.
30. Rincon-Choles H, Vasylyeva TL, Pergola PE, Bhandari B, Bhandari K, Zhang JH, Wang W, Gorin Y, Barnes JL, Abboud HE. ZO-1 expression and phosphorylation in diabetic nephropathy. Diabetes 2006; 55: 894-900.